PARSIPPANY, N.J., June 1, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson’s President and Chief Executive Officer, will provide an overview and update of the Company’s business at the 2011 Goldman Sachs 32nd Annual Global Healthcare Conference on Wednesday, June 8, 2011 at 11:00am Eastern Time at the Terranea Resort in Rancho Palos Verdes, California. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals’ Investor Relations Website at http://ir.watson.com. The webcast can also be accessed at the following URL:
http://cc.talkpoint.com/gold006/060711a_lr/?entity=4_BHJFWWH
An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women’s Health. Watson has operations in many of the world’s established and growing international markets.
For press release and other company information, visit Watson Pharmaceuticals’ Web site at http://www.watson.com.
(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO )
CONTACTS: | Investors: | |
Patty Eisenhaur | ||
(862) 261-8141 | ||
Media: | ||
Charlie Mayr | ||
(862) 261-8030 | ||
SOURCE Watson Pharmaceuticals, Inc.
